Bibliographic Details
| Title: |
Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial. |
| Authors: |
Ozer BH, Lindhorst SM, Merrell RT, Trevino CR, Rudnick JD, Avgeropoulos NG, Ramakrishna N, Khagi S, Rauf Y, Walbert T, Pan E, Youssef M, Fink KL, Mandel JJ, Taylor LP, Colman H, Dunbar EM, Paleologos N, Burton EC, Wu J, Leeper HE, Gonzalez J, Penas-Prado M, Raizer JJ, Veglia E, Craig S, Yuan Y, Chambers C, Wall K, Grajkowska E, Mendoza T, Armstrong TS, Gilbert MR |
| Source: |
MedRxiv : the preprint server for health sciences [medRxiv] 2026 Jun 24. Date of Electronic Publication: 2026 Jun 24. |
| Publication Type: |
Journal Article; Preprint |
| Journal Info: |
Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE |
| Database: |
MEDLINE Ultimate |
